Susquehanna International Group’s Ascendis Pharma A/S ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.42M Sell
28,062
-442,889
-94% -$99.3M 0.01% 3824
2025
Q4
$100M Buy
+470,951
New +$97.3M 0.14% 887
2025
Q3
Hold
0
12332
2025
Q2
Sell
-11,395
Closed -$1.86M 12611
2025
Q1
$1.78M Sell
11,395
-18,465
-62% -$2.64M ﹤0.01% 5788
2024
Q4
$4.11M Buy
29,860
+27,854
+1,389% +$3.66M 0.01% 3903
2024
Q3
$300K Sell
2,006
-4,307
-68% -$582K ﹤0.01% 9609
2024
Q2
$861K Buy
+6,313
New +$859K ﹤0.01% 6936
2024
Q1
Hold
0
12135
2023
Q4
Sell
-19,330
Closed -$1.93M 12312
2023
Q3
$1.81M Buy
19,330
+4,696
+32% +$439K ﹤0.01% 5325
2023
Q2
$1.31M Buy
+14,634
New +$1.27M ﹤0.01% 6071
2023
Q1
Sell
-7,081
Closed -$810K 12533
2022
Q4
$865K Sell
7,081
-38,381
-84% -$4.46M ﹤0.01% 6503
2022
Q3
$4.69M Buy
+45,462
New +$4.31M 0.01% 3265
2022
Q2
Sell
-36,587
Closed -$3.45M 12844
2022
Q1
$4.29M Buy
36,587
+10,092
+38% +$1.17M 0.01% 3904
2021
Q4
$3.56M Buy
26,495
+19,920
+303% +$2.96M 0.01% 4348
2021
Q3
$1.05M Sell
6,575
-15,043
-70% -$2.06M ﹤0.01% 7433
2021
Q2
$2.84M Buy
21,618
+12,592
+140% +$1.68M ﹤0.01% 5144
2021
Q1
$1.16M Sell
9,026
-7,508
-45% -$1.14M ﹤0.01% 7320
2020
Q4
$2.76M Sell
16,534
-5,373
-25% -$889K ﹤0.01% 4450
2020
Q3
$3.38M Buy
21,907
+18,520
+547% +$2.66M 0.01% 3664
2020
Q2
$501K Buy
3,387
+199
+6% +$27.3K ﹤0.01% 7353
2020
Q1
$359K Sell
3,188
-174,973
-98% -$22.7M ﹤0.01% 7631
2019
Q4
$24.8M Sell
178,161
-4,562
-2% -$507K 0.05% 1241
2019
Q3
$17.6M Buy
182,723
+108,876
+147% +$12.1M 0.04% 1441
2019
Q2
$8.5M Buy
+73,847
New +$8.84M 0.02% 2057
2019
Q1
Hold
0
8836
2018
Q4
Sell
-132,442
Closed -$8.32M 8952
2018
Q3
$9.38M Sell
132,442
-85,103
-39% -$5.86M 0.03% 2004
2018
Q2
$14.5M Buy
+217,545
New +$14.3M 0.05% 1587

Other funds holding ASND